Brief: Agile Therapeutics Posts Q3 Loss Per Share Of $0.18

Agile Therapeutics

02/11/2021 21:25

Nov 2 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
    * DELIVERED $1.3 MILLION IN NET PRODUCT SALES REVENUE IN Q3
    * Q3 LOSS PER SHARE $0.18
    * Q3 EARNINGS PER SHARE VIEW $-0.19, REVENUE VIEW $1.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3NMdKs 
Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))